FDA Adverse Event Malfunction Summary report: N

COBAS 8000 CORE UNIT

MDR report key: 4170043 · Received October 14, 2014

Report

Report Number
1823260-2014-07859
Event Type
Malfunction
Date Received
October 14, 2014
Date of Event
August 25, 2014
Report Date
October 14, 2014
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K100853
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER RECEIVED QUESTIONABLE THYROID RESULTS FOR ONE PATIENT. OF THE DATA PROVIDED, THE FREE TRIIODOTHYRONINE (FT3) RESULTS WERE DISCREPANT. THREE SAMPLES WERE COLLECTED FROM THE PATIENT. (B)(6) 2014: FT3 RESULT WAS 3.4 PG/ML. (B)(6) 2014: FT3 RESULT WAS 3.3 PG/ML. (B)(6) 2014: FT3 RESULT WAS 3.6 PG/ML. A SAMPLE FROM THE PATIENT WAS SUBMITTED FOR INVESTIGATION. THE COLLECTION DATE OF THE SAMPLE WAS UNKNOWN. THE FT3 RESULT BY CLIA METHOD ON A CENTAUR ANALYZER WAS 4.4 PG/ML. PEG TREATMENT WAS PERFORMED ON THE SAMPLE AND THE RECOVERY WAS 75.3%. INFORMATION CONCERNING IF ANY ERRONEOUS RESULT WAS REPORTED OUTSIDE THE LABORATORY OR IF THE PATIENT WAS ADVERSELY AFFECTED WAS REQUESTED, BUT WAS NOT PROVIDED. THE FT3 REAGENT LOT NUMBER AND EXPIRATION DATE WERE REQUESTED, BUT WERE NOT PROVIDED. AS NO ADDITIONAL PATIENT SAMPLE WAS AVAILABLE, FURTHER INVESTIGATION WAS NOT POSSIBLE. A SPECIFIC ROOT CAUSE COULD NOT BE IDENTIFIED. ADDITIONAL INFORMATION FOR FURTHER INVESTIGATION WAS REQUESTED BUT WAS NOT PROVIDED. A GENERAL REAGENT ISSUE COULD MOST LIKELY BE EXCLUDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
650892 COBAS 8000 CORE UNIT CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1 046 YR